Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – Quest Diagnostics introduces new Covid-19 semi-quantitative serology test service – BioIQ and Assurance Scientific Laboratories collaborate on new Covid-19 OTC at-home test kits

25 Feb 2021 (Last Updated February 25th, 2021 10:35)

Quest Diagnostics has introduced a new Covid-19 testing service that will provide insights into an individual’s immune response due to a recent or prior infection or vaccination. The US Food and Drug Administration (FDA) maintains that serology tests help in identifying antibodies that can prevent infection as well as identify those still at risk.

BioIQ has partnered with Assurance Scientific Laboratories to bring over-the-counter (OTC), gold standard RT-PCR Covid-19 testing to market. The direct-to-consumer format approved by the US Food and Drug Administration (FDA) under Emergency Use Authorization (EUA), gives asymptomatic individuals access to Covid-19 testing solutions without a prescription.

XPhyto Therapeutics has placed the first order for its rapid point-of-care SARS-CoV-2 RT-PCR test system from 3a-diagnostics, its exclusive diagnostic development partner. The first order is for 9,600 individual tests which are packaged in 200 kits including 48 tests each. The delivery of the first order is expected in mid-March 2021.

MJ Biotech has announced that its sterile, FDA-approved nasal specimen collection swabs for the RT-PCR Covid test have been Covid-19 product offerings. This Covid-19 test is in addition to the Covid-19 IgG/IgM antibody rapid test kits already being offered by MJ Biotech.